Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on September 9, 2026

Sep. 9, 2026

Aspire Rejuvenation Founder Tomo Marjanovic Built Heroes Program for Veterans and First Responders He Served Beside

Indeterminate EIN Presswire

Sep. 9, 2026

SHUFFLRR LAUNCHES AI BLOB: THE PRESENTATION THAT FOLLOWS THE CONVERSATION

Indeterminate EIN Presswire

Sep. 9, 2026

BrainCX AI Launches Interpreterly, an AI Phone Interpreter for Spanish-Speaking Callers

Indeterminate EIN Presswire

Sep. 9, 2026

PureCipher Enables Trust at the Center of the Artificial Intelligence Race

Indeterminate EIN Presswire

Sep. 9, 2026

Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the US

Indeterminate EIN Presswire

Sep. 9, 2026

Dr. Reya Weeks Continues Serving Oviedo Families as Their Trusted Local Dentist

Indeterminate EIN Presswire

Sep. 9, 2026

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

AdCare Hospital Expands Detox Services with New 12-Bed Unit, Helping More People Access Care in Worcester

Indeterminate GlobeNewswire

Sep. 9, 2026

Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Venus Concept Announces CEO Transition

Indeterminate GlobeNewswire

Sep. 9, 2026

CooperCompanies Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Sep. 9, 2026

CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization

Indeterminate GlobeNewswire

Sep. 9, 2026

NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

NANOBIOTIX Participera à la Conférence H.C. Wainwright 28th Annual Global Investment

Indeterminate GlobeNewswire

Sep. 9, 2026

Century Therapeutics Appoints Joseph Truitt to Board of Directors

Indeterminate GlobeNewswire

Sep. 9, 2026

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 9, 2026

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

Indeterminate GlobeNewswire